1026477-69-9

Upstream product

• 1027953-76-9 N-{4-[(3-bromo-phenyl)-hydroxy-methyl]-5-ethyl-2-methoxy-6-methyl-pyridin-3-yl}-2,2-dimethyl-propionamide 
• 197229-98-4 5-ethyl-2-methoxy-6-methyl-3-pivaloylaminopyridine 
• 3132-99-8 m-bromobenzoic aldehyde 

Downstream Products

• 1026442-80-7 3-{5-ethyl-3-[(2-methoxy-ethyl)-methyl-amino]-6-methyl-2-oxo-1,2-dihydro-pyridin-4-ylmethyl}-benzaldehyde 
• 248248-76-2 4-(3-bromo-benzyl)-5-ethyl-3-[(2-methoxy-ethyl)-methyl-amino]-6-methyl-1H-pyridin-2-one 
• 1025901-43-2 3-[5-ethyl-3-(ethylmethylamino)-6-methyl-2-oxo-1,2-dihydropyridin-4-ylmethyl]benzaldehyde 
• 1027825-48-4 4-(3-bromobenzyl)-5-ethyl-3-(ethylmethylamino)-6-methylpyridin-2(1H)-one 
• 1026595-25-4 4-(3-bromobenzyl)-5-ethyl-6-methyl-3-methylaminopyridin-2(1H)-one 

Relevant academic research and scientific papers

4-Benzyl- and 4-benzoyl-3-dimethylaminopyridin-2(1H)-ones, a new family of potent anti-HIV agents: Optimization and in vitro evaluation against clinically important HIV mutant strains

The 4-benzyl and 4-benzoyl-3-dimethylaminopyridinones 13 and 14 are representatives of a new class of highly potent non nucleoside type inhibitors of HIV-1 reverse transcriptase. To conduct SAR studies on these two lead compounds, 102 new analogues were p